Waters (NYSE:WAT) Releases Q3 2025 Earnings Guidance

Key Points

• Waters Corporation has updated its Q3 2025 guidance, projecting earnings per share between $3.150-$3.250, slightly above the consensus estimate of $3.234, while revenue expectations are set at $773.6-$788.4 million.
• Research analysts have mixed ratings on Waters, with Wells Fargo downgrading it from "strong-buy" to "hold" and lowering the price target to $330.00, while Bank of America increased its target to $375.00.
• Waters shares are currently priced at $290.77, with a market cap of $17.30 billion and a year-high of $423.56, indicating significant stock fluctuation over the past year.

Waters (NYSE:WAT - Get Free Report) updated its third quarter 2025 earnings guidance on Monday. The company provided earnings per share guidance of 3.150-3.250 for the period, compared to the consensus earnings per share estimate of 3.234. The company issued revenue guidance of $773.6 million-$788.4 million, compared to the consensus revenue estimate of $775.3 million. Waters also updated its FY 2025 guidance to 12.950-13.050 EPS.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on WAT shares. Wells Fargo & Company cut shares of Waters from a "strong-buy" rating to a "hold" rating and dropped their target price for the stock from $420.00 to $330.00 in a report on Tuesday, July 15th. UBS Group reiterated a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. Bank of America increased their price objective on shares of Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Robert W. Baird decreased their target price on shares of Waters from $374.00 to $352.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 16th. Finally, Sanford C. Bernstein set a $400.00 price target on shares of Waters and gave the stock an "outperform" rating in a report on Wednesday, April 16th. Ten investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $382.40.

Waters Stock Performance

Shares of WAT stock opened at $290.77 on Monday. The stock has a market capitalization of $17.30 billion, a PE ratio of 26.39, a PEG ratio of 2.87 and a beta of 1.04. Waters has a one year low of $279.61 and a one year high of $423.56. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.81 and a quick ratio of 1.28. The business's 50 day simple moving average is $332.57 and its 200 day simple moving average is $354.43.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, beating analysts' consensus estimates of $2.92 by $0.03. Waters had a net margin of 22.02% and a return on equity of 41.70%. As a group, research analysts forecast that Waters will post 12.86 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in WAT. Goldman Sachs Group Inc. boosted its position in shares of Waters by 3.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier's stock valued at $73,733,000 after purchasing an additional 6,976 shares in the last quarter. Brighton Jones LLC lifted its stake in Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier's stock valued at $471,000 after buying an additional 673 shares during the period. Empowered Funds LLC boosted its holdings in shares of Waters by 16.6% during the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier's stock worth $415,000 after buying an additional 160 shares in the last quarter. Finally, Integrated Wealth Concepts LLC grew its position in shares of Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier's stock worth $386,000 after buying an additional 30 shares during the period. 94.01% of the stock is owned by institutional investors.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.